Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
Open | $41.47 |
Close | $40.17 |
Volume / Avg. | 630.41K / 746.25K |
Day Range | $40.15 - $42.12 |
52 Wk Range | 22.11 - 53.18 |
Market Cap | $2.66B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 14.96% |
Days to Cover | 15.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Other companies in Celldex Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and PTC Therapeutics (NASDAQ:PTCT).
Celldex Therapeutics has a consensus price target of $68.50.
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $40.17 last updated September 23, 2024 at 4:26 PM EDT.
There are no upcoming dividends for Celldex Therapeutics.
Celldex Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Celldex Therapeutics.
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.